Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly those targeting cancer pathways. Its structure supports binding to specific enzyme active sites, making it valuable in developing targeted therapies for oncology. Also employed in the study of structure-activity relationships (SAR) to optimize drug potency and selectivity. Commonly utilized in preclinical studies to evaluate antitumor activity and pharmacokinetic behavior of new drug candidates.